Weekly oral HIV treatment looks good at two years

A once-weekly oral regimen combining the HIV capsid inhibitor lenacapavir and the experimental nucleoside reverse transcriptase translocation inhibitor islatravir maintained viral suppression, according to study results presented at the European…